Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma

Journal of Clinical Oncology

Volumn 30, Issue 33, 2012, Pages 4104-4110

  Van Hooff, Sander R ^a   Leusink, Frank K J ^a   Roepman, Paul ^b   Baatenburg De Jong, Robert J ^f   Speel, Ernst Jan M ^g   Van Den Brekel, Michiel W M ^c   Van Velthuysen, Marie Louise F ^c   Van Diest, Paul J ^a   Van Es, Robert J J ^a   Merkx, Matthias A W ^e   Kummer, J Alain ⁱ   Leemans, C René ^d   Schuuring, Ed ^h   Langendijk, Johannes A ^h   Lacko, Martin ^g   De Herdt, Maria J ^f   Jansen, Jeroen C ^j   Brakenhoff, Ruud H ^d   Slootweg, Piet J ^e   Takes, Robert P ^e   Holstege, Frank C P ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Agendia NV   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ ST ANTONIUS HOSPITAL   (Netherlands)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; COHORT ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE TRANSFER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME;

EID: 84869445079     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.4509     Document Type: Article

References (31)

1. Argiris A, Karamouzis MV, Raben D, et al: Head and neck cancer. Lancet 371:1695-1709, 2008
2. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150, 2006
3. Borgemeester MC, van den Brekel MW, van Tinteren H, et al: Ultrasound-guided aspiration cytology for the assessment of the clinically N0 neck: Factors influencing its accuracy. Head Neck 30:1505-1513, 2008
4. Ganly I, Patel S, Shah J: Early stage squamous cell cancer of the oral tongue: Clinicopathologic features affecting outcome. Cancer 118:101-111, 2012
5. Okura M, Aikawa T, Sawai NY, et al: Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 45:908-911, 2009
6. Wensing BM, Merkx MA, De Wilde PC, et al: Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma. Oral Oncol 46:87-91, 2010
7. Rodrigo JP, Shah JP, Silver CE, et al: Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck 33:1210-1219, 2010
8. Bradley PJ, Ferlito A, Silver CE, et al: Neck treatment and shoulder morbidity: Still a challenge. Head Neck 33:1060-1067, 2011
9. van Wilgen CP, Dijkstra PU, van der Laan BF, et al: Morbidity of the neck after head and neck cancer therapy. Head Neck 26:785-791, 2004
10. Dünne AA, Folz BJ, Kuropkat C, et al: Extent of surgical intervention in case of N0 neck in head and neck cancer patients: An analysis of data collection of 39 hospitals. Eur Arch Otorhinolaryngol 261:295-303, 2004
11. Werning JW, Heard D, Pagano C, et al: Elective management of the clinically negative neck by otolaryngologists in patients with oral tongue cancer. Arch Otolaryngol Head Neck Surg 129:83-88, 2003
12. van't Veer LJ, Bernards R: Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452:564-570, 2008
13. Roepman P, Wessels LF, Kettelarij N, et al: An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182-186, 2005
14. Roepman P, Kemmeren P, Wessels LF, et al: Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 66:2361-2366, 2006
15. Glas AM, Floore A, Delahaye LJ, et al: Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278, 2006
16. National Center for Biotechnology Information: Gene expression omnibus. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=pvwflwuyuyucglm&acc= GSE30788
17. Shi W, Kato H, Perez-Ordonez B, et al: Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 27:6213-6221, 2009
18. Hafkamp HC, Speel EJ, Haesevoets A, et al: A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 107:394-400, 2003
19. Alkureishi LW, Ross GL, Shoaib T, et al: Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 17:2459-2464, 2010
20. Civantos FJ, Zitsch RP, Schuller DE, et al: Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: Results of a prospective multi-institutional trial. J Clin Oncol 28:1395-1400, 2010
21. Chung CH, Parker JS, Karaca G, et al: Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5:489-500, 2004
22. O'Donnell RK, Kupferman M, Wei SJ, et al: Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24:1244-1251, 2005
23. Warner GC, Reis PP, Jurisica I, et al: Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 110:857-868, 2004
24. Bar Ad V, Chalian A: Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. Oral Oncol 44:817-822, 2008
25. Genden EM, Ferlito A, Silver CE, et al: Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol 267:1001-1017, 2010
26. D'Souza G, Kreimer AR, Viscidi R, et al: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944-1956, 2007
27. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
28. Chung CH, Gillison ML: Human papillomavirus in head and neck cancer: Its role in pathogenesis and clinical implications. Clin Cancer Res 15:6758-6762, 2009
29. Leemans CR, Braakhuis BJ, Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 11:9-22, 2011
30. Psyrri A, Gouveris P, Vermorken JB: Human papillomavirus-related head and neck tumors: Clinical and research implication. Curr Opin Oncol 21:201-205, 2009
31. Song T, Bi N, Gui L, et al: Elective neck dissection or "watchful waiting": Optimal management strategy for early stage N0 tongue carcinoma using decision analysis techniques. Chin Med J (Engl) 121:1646-1650, 2008